Estimation of 10 - year probability bone fracture in a selected sample of Palestinian people using fracture risk assessment tool

BMC Musculoskeletal Disorders

Waleed M Sweileh²  Samah W Al-Jabi³  Ansam F Sawalha²  Sa’ed H Zyoud²  Adham S Abu Taha²  Mai B Aker¹ 

[1] College of Graduate Studies, Public Health Program, An-Najah National University, Nablus, Palestine;Division of Pharmacology/ Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine;Division of Clinical Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

关键词: Palestine;    Osteoporosis;    FRAX;   

Others  :  1129535
DOI  :  10.1186/1471-2474-14-284

 received in 2013-05-24, accepted in 2013-10-02,  发布年份 2013

【 摘 要 】

Background

The Fracture Risk Assessment (FRAX) tool has been developed by the World Health Organization (WHO) to calculate 10-year probability hip fracture (HP) or major osteoporotic fracture (MOF). The objective of this study was to assess the 10-year probability of MOF and HF among a selected sample of Palestinian people.

Methods

A sample of 100 subjects was studied. Dual energy X-ray absorpitometry was performed to measure bone mineral density (BMD) which was then inserted into FRAX Palestine online WHO tool to calculate the 10-year probability of MOF and HF.

Results

The median age of participants was 61.5 years and the majority (79%) were females. The median (interquartile range) of femoral hip BMD was 0.82 (0.76-0.92) g/cm². The mean vertebral and hip T scores were -1.41 ± 0.13 SDs and -0.91 ± 0.10 SDs respectively. About one fifth of the sample (21%) had vertebral osteoporosis and 5% had hip osteoporosis. The median (interquartile range) 10-year probability of MOF and HF based on BMD were 3.7 (2.43-6.18)%, and 0.30 (0.10-0.68)% respectively.

Conclusion

Osteoporosis is common among Palestinian people above 50 years old. Bone fracture prevention strategies and research should be a priority in Palestine. Using FRAX might be a helpful screening tool in primary healthcare centres in Palestine.

【 授权许可】

   
2013 Aker et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Fig. 4.

【 参考文献 】

• [1]Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S: What's in a name? what constitutes the clinical diagnosis of osteoporosis? Osteoporos Int 2012, 23(8):2093-2097.
• [2]Jiang E, Wang Z, Meng Q, Li S, Wang F, Shao G, Zhang L: Study on bone density at various skeletal sites for the diagnosis of primary osteoporosis. Cell Biochem Biophys 2012, 64(1):1-3.
• [3]Jin H, Lu Y: Cost-saving tree-structured survival analysis for hip fracture of study of osteoporotic fractures data. Med Decis Making 2010, 31(2):299-307.
• [4]Sahota O, Morgan N, Moran CG: The direct cost of acute hip fracture care in care home residents in the UK. Osteoporos Int 2012, 23(3):917-920.
• [5]Riggs BL: MLI: the worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995, 17:505S-511S.
• [6]Kanis JOA, Johans Son H, Borgs Röm TF, ST Röm O, McCloskey E: FRAX® J a new tool for assessing fracture risk: clinical applications and intervention thresholds. Medicographia 2010, 32:32-39.
• [7]Brown JP, Josse RG: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002, 167(10 Suppl):S1-S34.
• [8]Brown JP, Fortier M, Frame H, Lalonde A, Papaioannou A, Senikas V, Yuen CK: Canadian consensus conference on osteoporosis, 2006 update. J Obstet Gynaecol Can 2006, 28(2 Suppl 1):S95-S112.
• [9]Dawson-Hughes BTA, Melton L, et al.: Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 2008, 19(4):449-458.
• [10]Giacaman R, Khatib R, Shabaneh L, Ramlawi A, Sabri B, Sabatinelli G, Khawaja M, Laurance T: Health status and health services in the occupied Palestinian territory. Lancet 2009, 373(9666):837-849.
• [11]Cooper C, Campion G, Melton LJ 3rd: Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992, 2(6):285-289.
• [12]Larijani B, Resch H, Bonjour JP, Meybodi HRA, Tehrani MRM: Osteoporosis in Iran, overview and management. Iranian Journal of Public Health 2007, 36:1-13. Supplement
• [13]Kamel HKHM, Tariq S, Perry HM, Morley JE: Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000, 109:326-328.
• [14]El-Dessouki N: Osteoporosis in postmenopausal Saudi women using X-ray bone densitometry. Saudi Med J 2003, 24:935-936.
• [15]Maalouf G, Gannage-Yared MH, Ezzedine J, Larijani B, Badawi S, Rached A, Zakroui L, Masri B, Azar E, Saba E, et al.: Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 2007, 7(2):131-143.
• [16]Abd-Alhameed I, Saba E, Darwish HM: Prevalence and awareness of osteoporosis among postmenopausal Palestinian women. Arch Osteoporos 2004, 5(1–2):111-118.
• [17]Borissova AM, Rashkov R, Boyanov M, Shinkov A, Popivanov P, Temelkova N, Vlahov J, Gavrailova M: Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50 years and older. Arch Osteoporos 2011, 6(1–2):189-195.
• [18]Li YM, Liu SH: Estimation of the 10-year Probability of Osteoporotic Fracture in Postmenopausal Taiwanese Women With FRAX. Tzu Chi Medical Journal 2010, 22(1):29-35.
• [19]Pluskiewicz W, Adamczyk P, Franek E, Leszczynski P, Sewerynek E, Wichrowska H, Napiorkowska L, Kostyk T, Stuss M, Stepien-Klos W, et al.: Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram. conformity between methods and their clinical utility. Bone 2010, 46(6):1661-1667.
• [20]Dawson-Hughes B: A revised clinician's guide to the prevention and treatment of osteoporosis. Journal of Clinical Endocrinology & Metabolism 2008, 93(7):2463-2465.
• [21]Trombetti AHF, Hoffmeyer P, Schurch M, Bonjour J, Rizzoli R: Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002, 13(9):731-737.
• [22]Cummings SRNM, Browner WS, Stone K, Fox KM, Ensrud KE, et al.: Risk factors for hip fracture in white women. N Engl J Med 1995, 332:767-773.
• [23]Van Staa TP LH, Abenhaim L, Zhang B, Cooper C: Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000, 39:1383-1389.
• [24]Marshall DJO, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
• [25]Ringe J: Osteoporosis in men. Medicographia 2010, 32:71-78.
• [26]Chrischilles EA, Butler CD, Davis CS, Wallace RB: A model of lifetime osteoporosis impact. Arch Intern Med 1991, 151(10):2026-2032.
• [27]Abdul-Rahim HF, Holmboe-Ottesen G, Stene LC, Husseini A, Giacaman R, Jervell J, Bjertness E: Obesity in a rural and an urban Palestinian West Bank population. Int J Obes Relat Metab Disord 2003, 27(1):140-146.